Bundamedik Tbk vs Catur Sentosa Adiprana Tbk. — how do they compare? Bundamedik Tbk trades at Rp188 (market cap 1.63T, 725.9K 24h volume), while Catur Sentosa Adiprana Tbk. trades at Rp304 (market cap 1.67T, 1.28M 24h volume). The key difference: Bundamedik Tbk and Catur Sentosa Adiprana Tbk. are close in size by market cap, and Catur Sentosa Adiprana Tbk. is more actively traded (1.28M versus 725.9K). Which is the better fit depends on your goals.
| BMHS | CSAP | |
|---|---|---|
Market Cap | 1.63T | 1.67T |
Volume | 725.9K | 1.28M |
Lot | 7.26K | 12.81K |
Turnover | 135.94M | 380.73M |
Average Price | 187.26 | 297.19 |
Value | 135.94M | 380.73M |
Indicative Equilibrium Price | 188 | 304 |
Indicative Equilibrium Volume | 1 | 21 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →Catur Sentosa Adiprana Tbk (the company) was established on 31 Dec 1983 based on Notaries Deed No. 93 and the deed of establishment was approved by the the Ministry of Justice dated Sep 18, 1983. Based on the Company’s stockholders’ circular resolution dated June 6, 2007, the stockholders approved the change in the legal status of the Company from a Limited Liability Company “Perseroan Terbatas” with Foreign Capital Investments facility to a Limited Liability Company “Perseroan Terbatas” with Non-Foreign Capital Investments facility/Domestic Capital Investments, including the revocation and/or cancellation of every existing agreement of the Company related to Foreign Capital Investments.
Read more on CSAP →